Aastrom Biosciences, Inc.
Dominos Farms Lobby K
24 Frank Lloyd Wright Drive
Ann Arbor,
MI 48105
United States - Map
Phone: 734-930-5555
Fax: 734-665-0485
Web Site: http://www.aastrom.com
| Aastrom Biosciences, Inc. engages in developing autologous cell products for the repair or regeneration of human tissue. Its proprietary tissue repair cell (TRC) technology involves the use of a patient's own cells to manufacture products to treat a range of chronic diseases and serious injuries. The companys TRC-based products contain increased numbers of stem and early progenitor cells, produced from a small amount of bone marrow collected from the patient. Aastroms development activities are focused on applying TRC technology to cardiac and vascular tissue regeneration. It focuses on cardiovascular regeneration and is conducting a Phase II clinical trial with dilated cardiomyopathy patients (the IMPACT-DCM clinical trial) and a Phase IIb clinical trial with critical limb ischemia patients (the RESTORE-CLI clinical trial). The company was founded in 1989 and is headquartered in Ann Arbor, Michigan. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. George W. Dunbar Jr., 62
Chief Exec. Officer, Pres, Chief Financial Officer, Principal Accounting Officer |
$
375.00K |
$
0 | Dr. Ronnda L. Bartel Ph.D., 50
VP of Technical Operations |
N/A
| N/A | Ms. Julie A. Caudill ,
Corp. Sec. and Controller |
N/A
| N/A | Kris M. Maly ,
Sr. Director of Communications & Admin. |
N/A
| N/A | Mr. Sheldon A. Schaffer Ph.D., 65
VP of Corp. Devel. & Intellectual Property |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.16% Nasdaq 
Profile
